Roche : virtual event on key ophthalmology data presented at the Angiogenesis 2022 Meeting
01/17/2022 | 08:05am EDT
Investor Update
Roche's virtual event on key ophthalmology data presented at the Angiogenesis 2022 Meeting
We are pleased to invite investors and analysts to participate in our virtual event on Monday,
14 February 2022, highlighting Roche data presented at the virtual Angiogenesis, Exudation, and Degeneration 2022 Meeting, from 11th to 12th February.
16:30 - 17:45 CET / 15:30 - 16:45 GMT 10:30 - 11:45 am EST / 7:30 - 8:45 am PST
The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for downloadat15:00 CETon the day of the event. >click here
Access to virtual event (pre-registration required)
Please pre-register for our webinar here*.
Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.
A replay of the webcast will be available via > ir.roche.com
Roche Holding AG published this content on 17 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 January 2022 13:04:16 UTC.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
